Track the Bellevue Life Sciences Acquisition Corp. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €97.7m. The latest transaction was reported on 27 March 2023 (J). Among the most active insiders: Hwang Kuk Hyoun. Every trade is accessible without an account.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 14,256 of 28,803 companies
52.3
score / 100
Value
57
Quality
48
FCF yld19%
Earn yld1.9%
EV/EBITDA15.4x
ROE3.0%
Gross mgn47%
Net mgn3.6%
Debt/EBITDA2.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Bellevue Life Sciences Acquisition Corp. is a special purpose acquisition company focused on the life sciences sector. It is listed on NASDAQ under the ticker symbol BLSA.